VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 24, 2007) - Med BioGene Inc. (TSX VENTURE:MBI), a life science company focused on the development and commercialization of genomic-based diagnostic and screening tests for cancer and cardiovascular disease, is pleased to announce the appointment of Melanie M. Mahtani, Ph.D. as Executive Advisor, Commercial Development.
